COLON-study Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that influence colorectal tumour recurrence, survival and quality of life

COLON-study Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that influence colorectal tumour recurrence, survival and quality of life - COLON-study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32845

Enrollment

1000

Registered

2010-04-27

Start date

2010-10-11

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients, male and female, newly diagnosed with colorectal cancer in any stage of the disease in one of the participating hospitals.

Exclusion criteria

Exclusion criteria: Non-dutch speaking, history of colorectal tumours or (partial) bowel resection, chronic inflammatory bowel disease, hereditary colorectal cancer syndromes, dementia or order mental condition that makes it impossible to fill out a questionnaire correctly.

Design outcomes

Primary

Measure	Time frame
Primairy outcomes are colorectal cancer recurrence and colorectal adenoma recurrence/occurence. This information will be extracted from hospital registries and the Dutch cancer registries. Quality of life will be assessed with a quality of life questionnaire (EORT-QLQ-C30 in combination with the module for colorectal cancer patients CR-29).	—

Secondary

Measure	Time frame
To assess dietary intake and dietary patterns we will ask participants to fill out a food frequency questionnaire. To assess nutritional status, we will analyze the concentration of folate, vitamin D and calcium in blood samples of all participants. We will use surgery reports and hospital data to assess in which patients resurgery is necessary and what the recovery time is. Toxicity of chemo therapy will be assessed with a questionnaire that is part of the regular care of patients who undergo chemo therapy. This will only be submitted to patients who have to undergo chemo therapy.	—

Measure

Time frame

To assess dietary intake and dietary patterns we will ask participants to fill out a food frequency questionnaire. To assess nutritional status, we will analyze the concentration of folate, vitamin D and calcium in blood samples of all participants. We will use surgery reports and hospital data to assess in which patients resurgery is necessary and what the recovery time is. Toxicity of chemo therapy will be assessed with a questionnaire that is part of the regular care of patients who undergo chemo therapy. This will only be submitted to patients who have to undergo chemo therapy.

—

Countries

Netherlands

Outcome results